Outcome Of Dose-Adjusted Decitabine Regimen Compared With FLAG Regimen In The Treatment Of Relapsed/Refractory Acute Myeloid Leukemia

被引：1
|
作者：
Wu, Qian
He, Guangsheng
Wu Depei
Sun, Aining
Qiu, Huiying
Jin, Zhengming
Miao, Miao
Tang, XiaoWen
Han, Yue
Shen, Yiming
Chen, Feng
Hu, Xiaohui
Jin, Song
Zhang, Xuhui
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.5031.5031
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5031
引用
收藏
页数：1
相关论文
共 50 条
  • [1] OUTCOME OF FLAG REGIMEN IN THE TREATMENT OF REFRACTORY OR RELAPSED ADULT ACUTE MYLOID LEUKEMIA
    Alwan, F.
    Matti, F.
    Naji, S.
    Almudhaffar, J.
    HAEMATOLOGICA, 2012, 97 : 507 - 507
  • [2] EFFECT OF FLAG REGIMEN IN TREATMENT OF CHILDREN WITH ACUTE REFRACTORY AND RELAPSED LEUKEMIA
    Lin, Y.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 213 - 213
  • [3] FLAG regimen with or without idarubicin in the treatment of refractory and relapsed acute myeloid leukemia: a single center experience
    Aljaber, Rana A.
    Abbasi, Salah
    Marei, Lina
    Dowairi, Mohammad
    Nazer, Lama H.
    PHARMACOTHERAPY, 2012, 32 (05): : E121 - E122
  • [4] Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia
    Lu Xi Song
    Li Xu
    Xiao Li
    Chun Kang Chang
    Yi Zhang
    Ling Yun Wu
    Qi He
    Qing Xia Zhang
    Xiang Li
    Annals of Hematology, 2012, 91 : 1879 - 1886
  • [5] Efficacy and safety of the combination of decitabine and CHAG priming regimen in the relapsed or refractory acute myeloid leukemia
    Wu, Yan
    Liang, Jinping
    Mi, Ruihua
    Wang, Lin
    Chen, Lin
    Wei, Xudong
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [6] Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia
    Song, Lu Xi
    Xu, Li
    Li, Xiao
    Chang, Chun Kang
    Zhang, Yi
    Wu, Ling Yun
    He, Qi
    Zhang, Qing Xia
    Li, Xiang
    ANNALS OF HEMATOLOGY, 2012, 91 (12) : 1879 - 1886
  • [7] Clinical study of Mito-FLAG regimen in treatment of relapsed acute myeloid leukemia
    Luo, Sheng
    Cai, Fangfang
    Jiang, Lei
    Zhang, Shenghui
    Shen, Zhijian
    Sun, Lan
    Gao, Shenmeng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (03) : 982 - 986
  • [8] FLAG-Ida Regimen as Bridge Therapy to Allotransplantation in Refractory/Relapsed Acute Myeloid Leukemia Patients
    Delia, Mario
    Pastore, Domenico
    Cariuccio, Paola
    Paseiolla, Crescenza
    Ricco, Alessandra
    Rossi, Antonella Russo
    Casieri, Paola
    Mestice, Anna
    Albano, Francesco
    Specchia, Giorgina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (11): : 767 - 773
  • [9] A Phase II Trial of the Double Epigenetic Priming Regimen Including Chidamide and Decitabine for Relapsed/Refractory Acute Myeloid Leukemia
    Yin, Jia
    Wan, Chao-Ling
    Zhang, Ling
    Zhang, Hao
    Bai, Lian
    Zhou, Hai-Xia
    Xu, Ming-Zhu
    Chen, Li-Yun
    Qian, Chong-Sheng
    Qiu, Hui-Ying
    Chen, Su-Ning
    Tang, Xiao-Wen
    Wu, De-Pei
    Zhang, Yan-Ming
    Sun, Ai-Ning
    Xue, Sheng-Li
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Feasibility of FLAG-IDA regimen in cases with relapsed/refractory acute leukemia cases
    Paydas, S
    Yavuz, S
    Disel, U
    ANNALS OF HEMATOLOGY, 2006, 85 (01) : 63 - 63
12345